Target intelligence / Profile preview

Chromosome 20 open reading frame 96 (C20orf96)

Target
C20orf96
Molecular classification
Other
01

Overview

Chromosome 20 open reading frame 96 (C20orf96) encodes an uncharacterized protein in humans, with the gene located on chromosome 20 (location: 20p13, reverse strand)[3]. The gene has several transcript splice variants, translating into proteins of various lengths (256–363 amino acids)[3]. Despite bioinformatic and transcriptomic analyses suggesting potential roles in brain evolution and tumor biology, no direct biological function or molecular mechanism has been fully established[1]. Particularly, mutations in C20orf96 have been identified in plasma cell-free DNA of neuroblastoma patients undergoing chemotherapy, where their presence correlates with disease status, making C20orf96 a proposed biomarker for this cancer subtype[1]. The gene is not currently established as a therapeutic target (receptor, enzyme, transporter, etc.), and its molecular classification remains as “other” until functional studies clarify its activities. No drugs are known to act on C20orf96, and no specific safety concerns or mechanisms of action are described in the literature to date. The protein’s tissue expression or possible physiological functions remain largely unknown, and no established disease causation (apart from its putative biomarker utility) has been described[1][3].

Other names
dJ1103G7.2CT096_HUMAN
02

Biological functions

Other (no specific functional role has been clearly defined; some evidence points to possible involvement in gene regulation and cellular signaling, but this remains uncharacterized[1])
03

Disease associations

Cancer (notably neuroblastoma, where it has been proposed as a potential biomarker for tumor progression and treatment response[1])Other (potential but unconfirmed relevance in neurological development or function)
04

Biomarkers

C20orf96 mutation rate in cell-free DNA has been linked as a potential biomarker for monitoring tumor progression and treatment response in refractory neuroblastoma[1]

Beyond the preview

Go deeper on Chromosome 20 open reading frame 96 (C20orf96).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromosome 20 open reading frame 96 (C20orf96).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call